申请人:Laboratoire L. Lafon
公开号:US04146647A1
公开(公告)日:1979-03-27
The present invention provides compounds of the formula: ##STR1## in which A is CH.sub.2, CHOH, CH.sub.2 O, CH.sub.2 S, CH.sub.2 NH, OCH.sub.2, SCH.sub.2, NH, NHCH.sub.2, NHCOCH.sub.2 or CH.sub.2 NHCH.sub.2, X.sub.1 is H, halogen, C.sub.1 -C.sub.4 -alkyl or C.sub.1 -C.sub.4 -alkoxy, X.sub.2 is halogen, C.sub.1 -C.sub.4 -alkyl or C.sub.1 -C.sub.4 -alkoxy, Z is 2-pyrimidinyl or C(.dbd.NR.sub.1)NHR.sub.2 (where R.sub.1 is H and R.sub.2 is H, OH or CH.sub.2 CO.sub.2 Et, or R.sub.1 and R.sub.2 together form CH.sub.2 CH.sub.2, CH.sub.2 CH.sub.2 CH.sub.2 or N.dbd.N), and their addition salts. The compounds of formula I and their salts are useful in therapy as hypotensive agents.
本发明提供了以下式子的化合物:##STR1##其中A为CH.sub.2,CHOH,CH.sub.2 O,CH.sub.2 S,CH.sub.2 NH,OCH.sub.2,SCH.sub.2,NH,NHCH.sub.2,NHCOCH.sub.2或CH.sub.2 NHCH.sub.2,X.sub.1为H,卤素,C.sub.1-C.sub.4烷基或C.sub.1-C.sub.4烷氧基,X.sub.2为卤素,C.sub.1-C.sub.4烷基或C.sub.1-C.sub.4烷氧基,Z为2-嘧啶基或C(.dbd.NR.sub.1)NHR.sub.2(其中R.sub.1为H,R.sub.2为H,OH或CH.sub.2 CO.sub.2 Et,或R.sub.1和R.sub.2一起形成CH.sub.2 CH.sub.2,CH.sub.2 CH.sub.2 CH.sub.2或N.dbd.N),以及它们的加合盐。式I的化合物及其盐在治疗高血压方面是有用的。